| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |